DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 09 · Volume 68 · 1992 DOI: 10.1055/s-008-39990

Original Article

238
Gallus, Alexander S; Cade, John F; Mills, K W; Murphy, Wendy: Apparent Lack of Synergism between Heparin and Dihydroergotamine in Prevention of Deep Vein Thrombosis after Elective Hip Replacement: a Randomised Double-Blind Trial Reported in Conjunction with an Overview of Previous Results
245
Lensing, Anthonie W A; van Beek, Edwin J R; Demers, Christine; Tiel-van Buul, Monique M C; Yakemchuk, Valerie; van Dongen, Annemarie; Coates, Geoffrey; Ginsberg, Jeffrey S; Hirsh, Jack; ten Cate, Jan Wouter; Büller, Harry R: Ventilation-Perfusion Lung Scanning and the Diagnosis of Pulmonary Embolism: Improvement of Observer Agreement by the Use of a Lung Segment Reference Chart
250
Teufelsbauer, H; Proidl, Sylvia; Havel, M; Vukovich, Th: Early Activation of Hemostasis during Cardiopulmonary Bypass: Evidence for Thrombin Mediated Hyperfibrinolysis
253
Vukovich, Thomas; Proidl, Sylvia; Knöbl, Paul; Teufelsbauer, Harald; Schnack, Christoph; Schernthaner, Guntram: The Effect of Insulin Treatment on the Balance between Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Type 2 Diabetic Patients
257
Agnelli, Giancarlo; Volpato, Raul; Radicchia, Stefano; Veschi, Franca; Di Filippo, Paolo; Lupattelli, Luciano; Nenci, Giuseppe G: Detection of Asymptomatic Deep Vein Thrombosis by Real-Time B-Mode Ultrasonography in Hip Surgery Patients
261
Banerjee, A K; Pearson, J; Gilliland, E L; Goss, D; Lewis, J D; Stirling, Y; Meade, T W: A Six Year Prospective Study of Fibrinogen and Other Risk Factors Associated with Mortality in Stable Claudicants
264
Raasveld, Maarten H M; Hack, C Erik; ten Berge, Ineke J M: Activation of Coagulation and Fibrinolysis Following OKT3 Administration to Renal Transplant Recipients: Association with Distinct Mediators
268
Borrell, Montserrat; Sala, Nuria; de Castellarnau, Conxita; Lopez, Silvia; Gari, Merce; Fontcuberta, Jordi: Immunoglobulin Fractions Isolated from Patients with Antiphospholipid Antibodies Prevent the Inactivation of Factor Va by Activated Protein C on Human Endothelial Cells
273
Nieuwenhuizen, W; Hoegee-De Nobel, E; Laterveer, R: A Rapid Monoclonal Antibody-Based Enzyme Immunoassay (EIA) for the Quantitative Determination of Soluble Fibrin in Plasma
278
Oosting, Janine D; Derksen, Ronald H W M; Blokzijl, Laya; Sixma, Jan J; de Groot, Philip G: Antiphospholipid Antibody Positive Sera Enhance Endothelial Cell Procoagulant Activity – Studies in a Thrombosis Model
285
Halbmayer, Walter-Michael; Mannhalter, Christine; Feichtinger, Christine; Rubi, Karl; Fischer, Michael: The Prevalence of Factor XII Deficiency in 103 Orally Anticoagulated Outpatients Suffering from Recurrent Venous and/or Arterial Thromboembolism
291
Wu, John K; Sheffield, William P; Blajchman, Morris A: Molecular Cloning and Cell-Free Expression of Mouse Antithrombin III
297
Galli, Monica; Comfurius, Paul; Barbui, Tiziano; Zwaal, Robert F A; Bevers, Edouard M: Anticoagulant Activity of β2-Glycoprotein I Is Potentiated by a Distinct Subgroup of Anticardiolipin Antibodies
301
Kitchen, S; Malia, R G; Preston, F E: A Comparison of Methods for the Measurement of Activated Factor VII
306
Paloma, M J; Páramo, J A; Rocha, E: Effect of DDAVP on Endotoxin-Induced Intravascular Coagulation in Rabbits
310
Kristensen, Hanne I; Østergaard, Per B; Nordfang, Ole; Abildgaard, Ulrich; Lindahl, Anne Karin: Effect of Tissue Factor Pathway Inhibitor (TFPI) in the HEPTEST® Assay and in an Amidolytic Anti Factor Xa Assay for LMW Heparin
315
Reed, Guy L; Matsueda, Gary R; Haber, Edgar: Platelet Factor XIII Increases the Fibrinolytic Resistance of Platelet-Rich Clots by Accelerating the Crosslinking of α2-Antiplasmin to Fibrin
321
Keber, Irena; Keber, Dušan; Stegnar, Mojca; Vene, Nina: Tissue Plasminogen Activator Release in Chronic Venous Hypertension due to Heart Failure
325
Andrew, M; Brooker, L; Leaker, M; Paes, B; Weitz, J: Fibrin Clot Lysis by Thrombolytic Agents Is Impaired in Newborns due to a Low Plasminogen Concentration
331
Agnelli, Giancarlo; Pascucci, Claudia; Colucci, Mario; Nenci, Giuseppe G; Mele, Antonio; Bürgi, Rolf; Heim, Jutta: Thrombolytic Activity of Two Chimeric Recombinant Plasminogen Activators (FK2tu-PA and K2tu-PA) in Rabbits
336
Imura, Yoshimi; Stassen, Jean-Marie; Vreys, Ingrid; Lesaffre, Emmanuel; Gold, Herman K; Collen, Désiré: Synergistic Antithrombotic Properties of G4120, a RGD-Containing Synthetic Peptide, and Argatroban, a Synthetic Thrombin Inhibitor, in a Hamster Femoral Vein Platelet-Rich Thrombosis Model
341
Suganuma, A; Nakashima, S; Okano, Y; Nozawa, Y: Mass Contents of Inositol 1,4,5-Trisphosphate and 1,2-Diacylglycerol in Human Platelets Stimulated with a Thromboxane Analogue and Thrombin
346
Peerschke, Ellinor I B: Effect of Stimulation on the Stabilization of Platelet-Fibrinogen Interactions
352
Malmgren, R; Grunfelt, S; Joseph, Rajiv: On the Significance of Different Aequorin Loading Techniques on Intracellular Aequorin Discharge, Baseline Calcium, Platelet Aggregation and Aequorin-Indicated Ca2+-Transients
357
Lorenzet, Roberto; Sobel, Joan H; Bini, Alessandra; Witte, Larry D: Low Molecular Weight Fibrinogen Degradation Products Stimulate the Release of Growth Factors from Endothelial Cells
364
van Dam-Mieras, M C E; Muller, A D; van Hinsbergh, V W M; Mullers, W J H A; Bomans, P H H; Bruggeman, C A: The Procoagulant Response of Cytomegalovirus Infected Endothelial Cells

Letters to the Editor

371
Peters, M; ten Cate, H; Sturk, A: Acquired Protein S Deficiency Might Be Associated with a Prethrombotic State During Estrogen Treatment for Tall Stature
373
Nesaratnam, S; Bawa, S; Scrutton, M C: Lack of an Acute Effect of Pb2+ on Platelet Aggregation
374
Özyılkan, E; Şimşek, H; Özdemir, O; Sivri, B; Kirazlı, Ş; Telatar, H: Plasminogen Activator Inhibitor-2 and Alpha-Fetoprotein in Various Liver Disease States
375
Ivankovic, Milenko; Pereira, Jaime; Germain, Alfredo; Opazo, Antonio; Mezzano, Diego: Pregnancy and the Bleeding Time